SLC16 Family: From Atomic Structure to Human Disease

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The solute carrier 16 (SLC16) family comprises membrane proteins vital for monocarboxylate transport.
• SLC16 transporters regulate nutrient transport, pH balance, and thyroid hormone homeostasis.
• Dysregulation of SLC16 transporters is linked to cancer, diabetes, and neurological disorders.

Purpose of the Study:

• To provide a structural overview of the SLC16 family.
• To elucidate the role of SLC16 transporters in cancer metabolism.
• To discuss the therapeutic potential of inhibiting SLC16 transporters in cancer treatment.

Main Methods:

• Review of existing literature on SLC16 transporters.
• Analysis of structural information from SLC16 homologs.
• Discussion of the implications of SLC16 function in cancer.

Main Results:

• SLC16 family members exhibit diverse transport functions.
• L-Lactate transporters within the SLC16 family are critical for tumor metabolism.
• SLC16 transporters are validated targets for anticancer drug development.

Conclusions:

• Structural insights offer a new perspective on SLC16 family function.
• Targeting SLC16 transporters presents a promising strategy for anticancer therapy.
• Understanding SLC16 roles is key to developing novel cancer treatments.